Cargando…

Developing Pseudovirus-Based Neutralization Assay against Omicron-Included SARS-CoV-2 Variants

The global spread of SARS-CoV-2 and its variants poses a serious threat to human health worldwide. Recently, the emergence of Omicron has presented a new challenge to the prevention and control of the COVID-19 pandemic. A convenient and reliable in vitro neutralization assay is an important method f...

Descripción completa

Detalles Bibliográficos
Autores principales:	Sun, Hancong, Xu, Jinghan, Zhang, Guanying, Han, Jin, Hao, Meng, Chen, Zhengshan, Fang, Ting, Chi, Xiangyang, Yu, Changming
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9231177/ https://www.ncbi.nlm.nih.gov/pubmed/35746803 http://dx.doi.org/10.3390/v14061332

Ejemplares similares

Broadly neutralizing antibodies against Omicron-included SARS-CoV-2 variants induced by vaccination
por: Chi, Xiangyang, et al.
Publicado: (2022)

Comprehensive structural analysis reveals broad-spectrum neutralizing antibodies against SARS-CoV-2 Omicron variants
por: Chi, Xiangyang, et al.
Publicado: (2023)

A Simplified SARS-CoV-2 Pseudovirus Neutralization Assay
por: Donofrio, Gaetano, et al.
Publicado: (2021)

Establishment and validation of a pseudovirus neutralization assay for SARS-CoV-2
por: Nie, Jianhui, et al.
Publicado: (2020)

Evaluation of Immunogenicity by Pseudovirus Neutralization Assays for SARS‐CoV‐2 Variants after Primary and Booster Immunization
por: Xie, Hui, et al.
Publicado: (2022)

Performance of commercial SARS-CoV-2 wild-type and Omicron BA.1 antibody assays compared with pseudovirus neutralization tests
por: Habermann, E., et al.
Publicado: (2023)

A high-throughput SARS-CoV-2 pseudovirus multiplex neutralization assay
por: Sievers, Benjamin Louis, et al.
Publicado: (2022)

SARS-CoV-2 pan-variant inhibitory peptides deter S1-ACE2 interaction and neutralize delta and omicron pseudoviruses
por: Shah, Masaud, et al.
Publicado: (2022)

Evaluation of a Pseudovirus Neutralization Assay for SARS-CoV-2 and Correlation with Live Virus-Based Micro Neutralization Assay
por: Tolah, Ahmed Majdi K., et al.
Publicado: (2021)

Deletion of the SARS-CoV-2 Spike Cytoplasmic Tail Increases Infectivity in Pseudovirus Neutralization Assays
por: Yu, Jingyou, et al.
Publicado: (2021)

Combining MOE Bioinformatics Analysis and In Vitro Pseudovirus Neutralization Assays to Predict the Neutralizing Ability of CV30 Monoclonal Antibody on SARS-CoV-2 Variants
por: Zhu, Yajuan, et al.
Publicado: (2023)

Calibration of Two Validated SARS-CoV-2 Pseudovirus Neutralization Assays for COVID-19 Vaccine Evaluation
por: Huang, Yunda, et al.
Publicado: (2021)

Calibration of Two Validated SARS-CoV-2 Pseudovirus Neutralization Assays for COVID-19 Vaccine Evaluation
por: Huang, Yunda, et al.
Publicado: (2021)

Calibration of two validated SARS-CoV-2 pseudovirus neutralization assays for COVID-19 vaccine evaluation
por: Huang, Yunda, et al.
Publicado: (2021)

Establishment of a pseudovirus neutralization assay based on SARS-CoV-2 S protein incorporated into lentiviral particles
por: Wang, Sheng, et al.
Publicado: (2022)

A bispecific nanobody dimer broadly neutralizes SARS-CoV-1 & 2 variants of concern and offers substantial protection against Omicron via low-dose intranasal administration
por: Ma, Huan, et al.
Publicado: (2022)

Antibodies elicited by SARS-CoV-2 infection or mRNA vaccines have reduced neutralizing activity against Beta and Omicron pseudoviruses
por: Sievers, Benjamin L., et al.
Publicado: (2022)

Comparative analysis of the neutralizing activity against SARS-CoV-2 Wuhan-Hu-1 strain and variants of concern: Performance evaluation of a pseudovirus-based neutralization assay
por: D’Apice, Luciana, et al.
Publicado: (2022)

A simple and safe antibody neutralization assay based on polio pseudoviruses
por: Jiang, Zheng, et al.
Publicado: (2018)

Broad-spectrum humanized monoclonal neutralizing antibody against SARS-CoV-2 variants, including the Omicron variant
por: Wen, Kun, et al.
Publicado: (2023)

Antibodies Targeting Two Epitopes in SARS-CoV-2 Neutralize Pseudoviruses with the Spike Proteins from Different Variants
por: Yang, Chee-Hing, et al.
Publicado: (2021)

Development of a Cell-Based SARS-CoV-2 Pseudovirus Neutralization Assay Using Imaging and Flow Cytometry Analysis
por: Izac, Jerilyn R., et al.
Publicado: (2023)

Vaccine Ab neutralization against Omicron and SARS-CoV-2 variants using neutralization and specific ELISA assays
por: Ferré, Valentine Marie, et al.
Publicado: (2022)

Plasma Neutralization of the SARS-CoV-2 Omicron Variant
por: Schmidt, Fabian, et al.
Publicado: (2021)

Neutralization and Stability of SARS-CoV-2 Omicron Variant
por: Zeng, Cong, et al.
Publicado: (2021)

A combination of cross-neutralizing antibodies synergizes to prevent SARS-CoV-2 and SARS-CoV pseudovirus infection
por: Liu, Hejun, et al.
Publicado: (2021)

A combination of cross-neutralizing antibodies synergizes to prevent SARS-CoV-2 and SARS-CoV pseudovirus infection
por: Liu, Hejun, et al.
Publicado: (2021)

Neutralization of SARS-CoV-2 pseudovirus using ACE2-engineered extracellular vesicles
por: Wu, Canhao, et al.
Publicado: (2022)

SARS-CoV-2 Antibody Neutralization Assay Platforms Based on Epitopes Sources: Live Virus, Pseudovirus, and Recombinant S Glycoprotein RBD
por: Septisetyani, Endah Puji, et al.
Publicado: (2021)

A Spike-destructing human antibody effectively neutralizes Omicron-included SARS-CoV-2 variants with therapeutic efficacy
por: Meng, Lu, et al.
Publicado: (2023)

A non-ACE2-blocking neutralizing antibody against Omicron-included SARS-CoV-2 variants
por: Duan, Xiaomin, et al.
Publicado: (2022)

Three SARS-CoV-2 antibodies provide broad and synergistic neutralization against variants of concern, including Omicron
por: Wang, Siling, et al.
Publicado: (2022)

Plasma neutralization properties of the SARS-CoV-2 Omicron variant
por: Schmidt, Fabian, et al.
Publicado: (2021)

Development of cell-based pseudovirus entry assay to identify potential viral entry inhibitors and neutralizing antibodies against SARS-CoV-2
por: Hu, Jie, et al.
Publicado: (2020)

Potent neutralizing monoclonal antibodies against Ebola virus isolated from vaccinated donors
por: Fan, Pengfei, et al.
Publicado: (2020)

Packaging of Rift Valley fever virus pseudoviruses and establishment of a neutralization assay method
por: Li, Yuetao, et al.
Publicado: (2018)

The Impact on Infectivity and Neutralization Efficiency of SARS-CoV-2 Lineage B.1.351 Pseudovirus
por: Kim, Yeong Jun, et al.
Publicado: (2021)

Inhibition of the Cell Uptake of Delta and Omicron SARS-CoV-2 Pseudoviruses by N-Acetylcysteine Irrespective of the Oxidoreductive Environment
por: La Maestra, Sebastiano, et al.
Publicado: (2022)

Human antibodies to SARS-CoV-2 with a recurring YYDRxG motif retain binding and neutralization to variants of concern including Omicron
por: Liu, Hejun, et al.
Publicado: (2022)

A Novel and Secure Pseudovirus Reporter System Based Assay for Neutralizing and Enhancing Antibody Assay Against Marburg Virus
por: Bi, Jinhao, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_17plka0rfg8koqb3m0f86aepuh